ELICIO THERAPEUTICS, INC. FINANCIAL STATEMENTS
Index to Consolidated Financial Statements
| | Page | |
Financial Statements for the Years Ended December 31, 2022 and 2021 | | | |
Report of Independent Registered Public Accounting Firm, Baker Tilly US, LLP, Tewskbary, MA PCAOB ID: 23 | | | F-2 |
Consolidated Balance Sheets | | | F-3 |
Consolidated Statements of Operations | | | F-4 |
Consolidated Statements of Convertible Preferred Stock and Stockholders’ Deficit | | | F-5 |
Consolidated Statements of Cash Flows | | | F-6 |
Notes to Consolidated Financial Statements | | | F-7 |